Organ and Tissue Transplantation and Alternative Market

Organ transplantation as a therapeutic strategy for patients with end-stage organ disease have been achieved due to greater insight into the immunobiology of graft rejection and better measures for surgical and medical management.
Organ and Tissue Transplantation and Alternative Market contains market size and forecasts of Organ and Tissue Transplantation and Alternative in global, including the following market information:
Global Organ and Tissue Transplantation and Alternative Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Organ and Tissue Transplantation and Alternative Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Organ and Tissue Transplantation and Alternative companies in 2021 (%)
The global Organ and Tissue Transplantation and Alternative market was valued at 100700 million in 2021 and is projected to reach US$ 153440 million by 2028, at a CAGR of 6.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Organ Transplantation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Organ and Tissue Transplantation and Alternative include Abbott, Arthrex, Biomet, Bristol-Myers, Centacor, CryoLife, Inc., Dr. Franz K?hler Chemie GmbH, Novartis and Organ Transport Systems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Organ and Tissue Transplantation and Alternative manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Organ and Tissue Transplantation and Alternative Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Organ and Tissue Transplantation and Alternative Market Segment Percentages, by Type, 2021 (%)
Organ Transplantation
Tissue Transplantation
Cell Transplantation
Global Organ and Tissue Transplantation and Alternative Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Organ and Tissue Transplantation and Alternative Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Laboratory
Global Organ and Tissue Transplantation and Alternative Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Organ and Tissue Transplantation and Alternative Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Organ and Tissue Transplantation and Alternative revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Organ and Tissue Transplantation and Alternative revenues share in global market, 2021 (%)
Key companies Organ and Tissue Transplantation and Alternative sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Organ and Tissue Transplantation and Alternative sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Arthrex
Biomet
Bristol-Myers
Centacor
CryoLife, Inc.
Dr. Franz K?hler Chemie GmbH
Novartis
Organ Transport Systems
Organogenesis, Inc.
XVIVO Perfusion AB